The possibility of a big COVID-19 rebound in China over the next two or three months is remote as 80% of people have been infected, a prominent government scientist says.
---
DW 時評作家長平指出,中國軍隊減少擾台軍演一次兩次,就可以讓全中國老年新冠感染者免費用上輝瑞 Paxlovid,數以百萬計的家庭免於喪親之痛。
---
輝瑞生產的新冠治療藥物Paxlovid未能列入中國醫保名單,但該藥從去年12月初大規模感染潮開始就一藥難求,在海外的華人紛紛開始向國內郵寄Paxlovid,如何讓藥送到,大家想盡了各種辦法
----


沒有留言:
張貼留言